DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call
DaVita Inc. (NYSE: DVA) has scheduled its second quarter 2025 earnings conference call for Tuesday, August 5, 2025, at 5:00 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DaVita Inc. (NYSE: DVA) has scheduled its second quarter 2025 earnings conference call for Tuesday, August 5, 2025, at 5:00 p.m. Eastern Time. The company will release its financial results after the market closes on the same day.
Investors can access the call through a webcast on DaVita's investor relations website or by dialing 877-918-6630 (US) or 517-308-9042 (International). Participants should provide the password "Earnings" when joining. A replay will be available on the company's website, but no telephone replay option will be provided.
Details
News Market Reaction – DVA
The recorded move for DVA in the trading session of this news was -1.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Tuesday, August 5, 2025
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2025, DaVita served approximately 282,000 patients at 3,173 outpatient dialysis centers, of which 2,661 centers were located in the United States and 512 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-2nd-quarter-2025-investor-conference-call-302508353.html
SOURCE DaVita
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.